Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

tranexamic acid

A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action.
Synonym:tranhexamic acid
US brand name:Cyklokapron
Lysteda
Foreign brand name:Amixam
Cyclokapron
Hemostan
Prexam
Tranofast
Chemical structure:cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-
Search NCI's Drug Dictionary